- Home
- BGLC vs CHNR Comparison
BGLC vs CHNR Comparison
Compare BGLC & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- CHNR
- Stock Information
- Founded
- BGLC 2017
- CHNR N/A
- Country
- BGLC Malaysia
- CHNR China
- Employees
- BGLC N/A
- CHNR N/A
- Industry
- BGLC Medical Specialities
- CHNR Precious Metals
- Sector
- BGLC Health Care
- CHNR Basic Materials
- Exchange
- BGLC Nasdaq
- CHNR Nasdaq
- Market Cap
- BGLC 10.7M
- CHNR 4.6M
- IPO Year
- BGLC N/A
- CHNR 1995
- Fundamental
- Price
- BGLC $5.09
- CHNR $3.68
- Analyst Decision
- BGLC
- CHNR
- Analyst Count
- BGLC 0
- CHNR 0
- Target Price
- BGLC N/A
- CHNR N/A
- AVG Volume (30 Days)
- BGLC 2.7M
- CHNR 37.9K
- Earning Date
- BGLC 08-13-2025
- CHNR 05-15-2025
- Dividend Yield
- BGLC N/A
- CHNR N/A
- EPS Growth
- BGLC N/A
- CHNR N/A
- EPS
- BGLC N/A
- CHNR N/A
- Revenue
- BGLC $9,265,870.00
- CHNR N/A
- Revenue This Year
- BGLC N/A
- CHNR N/A
- Revenue Next Year
- BGLC N/A
- CHNR N/A
- P/E Ratio
- BGLC N/A
- CHNR N/A
- Revenue Growth
- BGLC N/A
- CHNR N/A
- 52 Week Low
- BGLC $2.01
- CHNR $3.35
- 52 Week High
- BGLC $15.60
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- BGLC 52.61
- CHNR 43.59
- Support Level
- BGLC $5.33
- CHNR $3.35
- Resistance Level
- BGLC $6.39
- CHNR $3.71
- Average True Range (ATR)
- BGLC 1.18
- CHNR 0.30
- MACD
- BGLC 0.10
- CHNR -0.03
- Stochastic Oscillator
- BGLC 19.15
- CHNR 29.41
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.